Moxidel - CV Dry Syrup is a dual-action antibiotic formulation combining Amoxycillin (200mg) and Potassium Clavulanate (28.5mg) in a dry syrup matrix, designed for stability and ease of reconstitution. The formulation leverages advanced pharmaceutical engineering to ensure uniform dispersion of active ingredients, maintaining potency and bioavailability. The dry syrup format (DPCO) allows for precise dosing and compatibility with various reconstitution methods, making it ideal for bulk manufacturing. The combination of Amoxycillin and Clavulanate addresses beta-lactamase-producing pathogens, enhancing therapeutic efficacy. From a formulation perspective, the product is engineered to meet stringent pharmaceutical standards, ensuring consistency in physicochemical properties, dissolution rates, and microbial safety. The dry syrup base is formulated using high-purity excipients and a controlled drying process to preserve active pharmaceutical ingredients (APIs) and ensure shelf stability.
Manufacturing Capability
Delwis Healthcare’s manufacturing infrastructure is equipped to produce Moxidel - CV Dry Syrup with precision and scalability. The facility adheres to current Good Manufacturing Practices (cGMP) and maintains a Class 10,000 cleanroom environment for sterile processing, ensuring contamination-free production. Advanced automated systems are integrated for accurate dosing, mixing, and drying, minimizing human error and enhancing batch consistency. The dry syrup formulation is processed using a proprietary drying technology that preserves API integrity while ensuring optimal flow properties for packaging. The facility is designed for large-scale production, with modular systems enabling flexible capacity adjustments to meet bulk supply demands. Quality systems include real-time monitoring of critical parameters such as temperature, humidity, and particle count, ensuring compliance with international pharmaceutical standards.
Available Strengths and Packaging
The product is formulated as a 200mg Amoxycillin + 28.5mg Potassium Clavulanate dry syrup, available in a 30ml packaging with Water for Injection (WFI) and an outer protective layer. The 30ml volume is optimized for reconstitution, ensuring accurate dosing for clinical use. The WFI component ensures sterility and compatibility with reconstitution protocols, while the outer packaging provides tamper-evidence and environmental protection. This packaging format is suitable for both domestic and international markets, supporting seamless integration into supply chains.
Contract Manufacturing / Third Party Manufacturing
Delwis Healthcare offers comprehensive contract manufacturing and third-party manufacturing services tailored to pharmaceutical buyers’ needs. Our private label manufacturing capabilities allow clients to produce branded products under their own trademarks, with full customization of packaging, labeling, and formulation parameters. We specialize in bulk supply solutions, enabling partners to scale production efficiently while maintaining compliance with global regulatory standards. Our team provides end-to-end support, from formulation development to final packaging, ensuring seamless integration into clients’ supply chains. Whether for domestic or international markets, Delwis Healthcare’s flexible manufacturing framework supports diverse requirements, including API sourcing, dosage form customization, and regulatory documentation.
Quality Assurance
Quality assurance is a cornerstone of Delwis Healthcare’s manufacturing process. Every batch of Moxidel - CV Dry Syrup undergoes rigorous testing, including in-process checks for API content, pH, clarity, and microbial load. Analytical validation methods such as HPLC and UV spectrophotometry ensure accuracy in potency and purity. Final product testing includes dissolution profiling, stability studies, and sterility testing to meet international pharmacopeia standards. Our quality control systems are ISO 9001-certified, with dedicated laboratories equipped for advanced analytical testing. All processes are documented to ensure traceability and compliance with regulatory requirements, providing pharmaceutical buyers with confidence in product consistency and safety.
Regulatory Compliance
Delwis Healthcare ensures full compliance with Good Manufacturing Practices (GMP), World Health Organization (WHO) guidelines, and international ISO standards (ISO 9001, ISO 14001). Our facility is regularly audited by regulatory authorities and holds certifications for pharmaceutical manufacturing, ensuring adherence to global quality benchmarks. The product meets specifications outlined in the United States Pharmacopeia (USP) and British Pharmacopeia (BP), facilitating global market access. Compliance with regulatory frameworks such as the FDA’s Current Good Manufacturing Practice (CGMP) and the European Medicines Agency (EMA) guidelines ensures that Moxidel - CV Dry Syrup is suitable for export to major pharmaceutical markets.
Global Supply Capability
Delwis Healthcare is a trusted exporter with a robust international distribution network spanning over 50 countries. Our bulk supply capacity is designed to meet large-scale demand, supported by a logistics infrastructure that ensures timely delivery and compliance with import regulations. The company’s supply chain is optimized for reliability, with redundant systems in place to mitigate disruptions. Whether supplying to emerging markets or developed regions, Delwis Healthcare’s export capabilities are backed by compliance with international trade standards, including HS code alignment and documentation for customs clearance. The 30ml packaging format is compatible with global distribution channels, ensuring seamless integration into regional supply chains.
Why Choose Us
Pharmaceutical distributors, exporters, and contract manufacturing partners choose Delwis Healthcare for its unwavering commitment to quality, compliance, and scalability. Our expertise in dry syrup formulation, combined with state-of-the-art manufacturing infrastructure, ensures consistent product performance. As a trusted supplier, we offer competitive pricing, rapid turnaround times, and full regulatory support, enabling clients to enter global markets with confidence. Our focus on innovation and sustainability further strengthens our appeal, positioning us as a reliable partner for long-term collaboration.
Bulk Supply Inquiry
Delwis Healthcare provides reliable bulk supply solutions for Moxidel - CV Dry Syrup. For inquiries regarding large-scale procurement, please contact our team at info@delwishealthcare.com.
FAQs
What manufacturing standards does Delwis Healthcare follow for Moxidel - CV Dry Syrup?
Our production adheres to cGMP, WHO guidelines, and ISO 9001 standards, ensuring compliance with global regulatory requirements.
Can the product be customized for private label manufacturing?
Yes, we offer private label manufacturing services, allowing clients to brand the product under their own trademark.
What is the shelf life of Moxidel - CV Dry Syrup?
The product has a shelf life of 24 months when stored under recommended conditions, as validated through stability studies.
Is the 30ml packaging suitable for reconstitution?
Yes, the 30ml volume is optimized for accurate reconstitution, ensuring consistent dosing for clinical use.
What certifications does Delwis Healthcare hold for export?
Our facility is certified under ISO 9001, ISO 14001, and complies with FDA CGMP and EMA guidelines for global export.
Can you provide bulk supply for international markets?
Yes, we specialize in bulk supply and have a global distribution network to support exports to over 50 countries.
What quality control measures are in place for batch testing?
Each batch undergoes rigorous testing, including HPLC, UV spectrophotometry, and microbial analysis, to ensure potency and purity.
How do you ensure supply chain reliability?
Our logistics infrastructure includes redundant systems and real-time tracking, ensuring timely delivery and compliance with international trade regulations.
What is the minimum order quantity for bulk procurement?
Minimum order quantities are flexible and can be tailored to meet the specific needs of pharmaceutical buyers.
Can the packaging format be modified for different markets?
Yes, we offer customization of packaging and labeling to meet regional regulatory and market-specific requirements.
